Breakpoint To Chair and Present at DDR Inhibitors Summit 2024

Breakpoint’s Managing Directors Daniel Speidel and Jon Hollick will attend the DDR Inhibitors Summit 2024 in Boston (30 January- 1 February 2024). At this international meeting, experts from industry and academia gather to share and discuss updates in the development of novel therapeutics targeting the DNA Damage response in cancer cells.

Daniel Speidel will chair the conference and also moderate a panel entitled “What Makes the Perfect Next-Generation DDR Inhibitor Target?”. In addition, Jon Hollick will present a poster highlighting new data from Breakpoint’s PolQ programme.